ES484926A1 - Metodo para producir derivados polipeptidicos y sus sales - Google Patents

Metodo para producir derivados polipeptidicos y sus sales

Info

Publication number
ES484926A1
ES484926A1 ES484926A ES484926A ES484926A1 ES 484926 A1 ES484926 A1 ES 484926A1 ES 484926 A ES484926 A ES 484926A ES 484926 A ES484926 A ES 484926A ES 484926 A1 ES484926 A1 ES 484926A1
Authority
ES
Spain
Prior art keywords
group
hydrogen
acid addition
compounds
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES484926A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordisk Insulinlaboratorium
Original Assignee
Nordisk Insulinlaboratorium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlaboratorium filed Critical Nordisk Insulinlaboratorium
Publication of ES484926A1 publication Critical patent/ES484926A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/645Secretins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Método para producir derivados polipeptídicos y sus sales, siendo tales derivados de la fórmula general: a-x-y-arg-leu-d en donde x representa un enlace, un solo aminoácido o un péptido que tiene hasta 10 aminoácidos en la cadena, y representa gln, glu o glu, a representa hidrógeno o un pequeño grupo protector del grupo alfa-amino del aminoácido N terminal, d representa -NR1R2, en donde R1 y R2 se eligen del grupo formado por hidrógeno, alquilo C1-C6 y cicloalquilo C3- C8 o R1 y R2 conjuntamente con el átomo de nitrógeno enlazado forman un grupo heterocíclico que contiene opcionalmente un heteroátomo adicional, o d representa -OR3, en donde R3 se elige del grupo formado por hidrógeno, alquilo C1-C6, cicloalquilo C3-C8, bencilo, fenacilo, ftalimidonetilo, beta- metiltioetilo, 4-picolilo y bencilo substituido, en donde los substituyentes se eligen del grupo formado por nitro, metoxi, metilo y halógeno, y siendo sus sales las de adición de ácido con ácidos aceptables para el organismo.
ES484926A 1978-09-28 1979-09-28 Metodo para producir derivados polipeptidicos y sus sales Expired ES484926A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK430478 1978-09-28

Publications (1)

Publication Number Publication Date
ES484926A1 true ES484926A1 (es) 1980-07-01

Family

ID=8132257

Family Applications (2)

Application Number Title Priority Date Filing Date
ES484928A Expired ES484928A1 (es) 1978-09-28 1979-09-28 Procedimiento para producir derivados polipeptidicos y sus sales
ES484926A Expired ES484926A1 (es) 1978-09-28 1979-09-28 Metodo para producir derivados polipeptidicos y sus sales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES484928A Expired ES484928A1 (es) 1978-09-28 1979-09-28 Procedimiento para producir derivados polipeptidicos y sus sales

Country Status (16)

Country Link
US (1) US4356119A (es)
JP (2) JPS5569550A (es)
AT (1) AT375338B (es)
AU (2) AU526149B2 (es)
BE (2) BE879087A (es)
CA (2) CA1140116A (es)
CH (2) CH648567A5 (es)
DE (2) DE2939109A1 (es)
ES (2) ES484928A1 (es)
FI (2) FI68245C (es)
FR (2) FR2437399A1 (es)
GB (2) GB2031436B (es)
IT (2) IT1125421B (es)
NL (2) NL7907188A (es)
NO (2) NO148923C (es)
SE (2) SE7907938L (es)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA685075A (en) * 1964-04-21 Schwyzer Robert Polypeptides and process for their manufacture
CA798855A (en) * 1968-11-12 Bernardi Luigi Process for preparing a new undecapeptide
CA616330A (en) * 1961-03-14 Schwyzer Robert Polypeptide and derivatives thereof and process for their manfuacture
GB1064417A (en) * 1963-12-09 1967-04-05 Kyowa Hakko Kogyo Kk Process for the preparation of copolypeptides
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175988C (nl) * 1972-05-24 1985-02-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4110321A (en) * 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin

Also Published As

Publication number Publication date
AU5124679A (en) 1980-04-03
JPS5576849A (en) 1980-06-10
GB2031435A (en) 1980-04-23
AU526149B2 (en) 1982-12-16
ES484928A1 (es) 1980-07-01
CH648567A5 (de) 1985-03-29
FI68245B (fi) 1985-04-30
NO793112L (no) 1980-03-31
DE2939135A1 (de) 1980-04-17
NO148922B (no) 1983-10-03
FR2437400B1 (es) 1984-06-15
NL7907188A (nl) 1980-04-01
AU533684B2 (en) 1983-12-08
NL7907187A (nl) 1980-04-01
GB2031436B (en) 1982-10-20
US4356119A (en) 1982-10-26
FR2437399A1 (fr) 1980-04-25
FI68244C (fi) 1985-08-12
NO793111L (no) 1980-03-31
BE879086A (fr) 1980-03-28
NO148923C (no) 1984-01-11
FR2437400A1 (fr) 1980-04-25
IT1125421B (it) 1986-05-14
FR2437399B1 (es) 1983-01-28
AU5124579A (en) 1980-04-03
GB2031435B (en) 1982-11-10
FI68244B (fi) 1985-04-30
CA1140116A (en) 1983-01-25
SE7907939L (sv) 1980-03-29
JPS5569550A (en) 1980-05-26
ATA634679A (de) 1983-12-15
BE879087A (fr) 1980-03-28
NO148922C (no) 1984-01-11
NO148923B (no) 1983-10-03
IT7926112A0 (it) 1979-09-28
IT1125422B (it) 1986-05-14
SE7907938L (sv) 1980-03-29
AT375338B (de) 1984-07-25
DE2939109A1 (de) 1980-04-10
GB2031436A (en) 1980-04-23
CH648568A5 (de) 1985-03-29
CA1158640A (en) 1983-12-13
FI793001A7 (fi) 1980-03-29
IT7926111A0 (it) 1979-09-28
FI68245C (fi) 1985-08-12
FI793002A7 (fi) 1980-03-29

Similar Documents

Publication Publication Date Title
ES485274A1 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina
ES8706672A1 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
DK346276A (da) Fremgangsmade til fremstilling af alfa-phenylbenzylidenderivater af aminosyrer
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
DK517076A (da) Fremgangsmade til fremstilling af heterocycliske amino-alkoholderivater
ES8707211A1 (es) Un procedimiento para la preparacion de derivados de dioxido de benzotiazina
SE7606224L (sv) Forfarande for framstellning av heterocykliska acylaminoderivat
DK29285A (da) Methylendiphosphonsyrederivater og fremgangsmaade til fremstilling deraf samt antireumatiske farmaceutiske midler indeholdende derivaterne
ES8801211A1 (es) Un procedimiento para preparar derivados de quinolona
IT1055787B (it) Procedimento di preparazione dell amino 4 fenil 2 amino 5 benzimidazolo
IT1143918B (it) Derivati di epossisuccinil ammino acido dotati di attivita2 inibitrice su tiol proteasi
ES484926A1 (es) Metodo para producir derivados polipeptidicos y sus sales
BG31070A3 (bg) Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
ES8200884A1 (es) Un metodo de preparar derivados de fenil-piperazina farma- ceuticamente activos
DK442377A (da) Fremgangsmade til fremstilling af aminosyrederivater
ES8707550A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos.
AR228945A1 (es) Procedimiento para preparar derivados n-sustituidos del acido aziridina-2-carboxilico
IT8022148A0 (it) Amminoacil derivati di acidi mercaptoacil amminici.
ES448619A1 (es) Procedimiento para preparar acidos quinolina-3-carboxilicos.
ES8403895A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirimidina.
ES8506601A1 (es) Un procedimiento para la preparacion de derivados de benzamida
ATE1240T1 (de) Alpha-aminophenylessigsaeurederivate zur verwendung bei der behandlung von entzuendungen sowie neue alpha-aminophenylessigsaeurederivate.
IT1091105B (it) Procedimento per la produzione di acidi 2-carbammoil-fosfinici n-sostituiti
ES484246A1 (es) Procedimiento de preparacion de nuevos derivados de ortoclo-robenzoil-2-cloro-4 glicilanilidas